Nitric oxide (EDRF) enhances the vasorelaxing effect of dihydropyridine calcium antagonists in isolated human middle cerebral arteries

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 2, 1996, Pages 101-104

  Akopov, S E ^a,b  

^a YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

calcium antagonists; endothelium; nitric oxide; vessel relaxation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; INDOMETACIN; ISRADIPINE; LACIDIPINE; N(G) NITROARGININE; NIFEDIPINE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA;

ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; ENDOTHELIUM; HUMAN; HUMAN TISSUE; MIDDLE CEREBRAL ARTERY; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADULT; ARGININE; CALCIUM CHANNEL BLOCKERS; CEREBRAL ARTERIES; CYCLOOXYGENASE INHIBITORS; DIHYDROPYRIDINES; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; INDOMETHACIN; ISRADIPINE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; VASODILATOR AGENTS;

EID: 0029970999     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Moncada, S., Palmer, R.M.J., Higgs, A.E Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43: 109-42.
2. Gardiner, S.M., Bennett, T. Endothelial-derived relaxing factors: Focus on nitric oxide. In: Vascular Innervation and Receptor Mechanisms: New Perspectives. Academic Press: New York, 1993, 41-85.
3. Vanhoutte, P.M. Role of calcium and endothelium in hypertension, cardiovascular disease, and subsequent vascular events. J Cardiovasc Pharmacol 1992, 19 (Suppl. 3): S6-10.
4. Akopov, S.E. Calcium antagonists in cerebral ischemia: Experimental basis and clinical experience. Drugs Today/ Med Actual 1994, 30: 171-210.
5. Schabert, A., Bauer, R., Busse, R. A photoelectric devise for the recording of diameter changes in opaque and transparent blood vessels in vitro. Pflugers Archiv 1980, 385: 239-42.
6. Guyton, J.R., Rosenberg, R.D., Clowes, A.W., Karnovsky, M.J. Inhibition of rat arterial smooth muscle cell proliferation by heparin Circ Res 1980, 46: 625-34.
7. Luscher, T.F., Yang, Z. Calcium antagonists and ACE inhibitors: Effect on endothelium and vascular smooth muscle. Drugs 1993, 46 (Suppl. 2): 121-32.
8. Vilaine, J., Biondi, M., Villeneuve, N., Feleton, M., Peglion, J., Vanhoutte, P. The calcium channel antagonist S11568 causes endothelium-dependent relaxation in canine arteries. Eur J Pharmacol 1991, 197: 41-8.
9. Gunther, J., Dhein, S., Rosen, R., Klaus, W., Fricke, U. Nitric oxide (EDRF) enhances the vasorelaxing effects of nitrendipine in various isolated arteries Basic Res Cardiol 1992, 87, 452-60.
10. Van Zwieten, P., Pfaffendorf, M. Similarities and differences between calcium antagonists: Pharmacological aspects. J Hypertens 1993, 11 (Suppl. 1): S3-11.
11. Rubanyi, G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993, 22(Suppl. 4): S1-14.
12. Meidell, R.S. Endothelial dysfunction and vascular disease. Amer J Med Sci 1994, 307: 378-89.